Increased skin barrier disruption by sodium lauryl sulfate in mice expressing a constitutively active STAT6 in T cells

Sonia C. Dasilva, Ravi P. Sahu, Raymond Konger, Susan Perkins, Mark Kaplan, Jeffrey Travers

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Atopic dermatitis (AD) is a pruritic, chronic inflammatory skin disease that affects 10-20% of children and 1-3% of adults worldwide. Recent studies have indicated that the ability of Th2 cytokines, such as interleukin-4 (IL-4) to regulate skin barrier function may be a predisposing factor for AD development. The present studies examined the ability of increased Th2 activity to affect cutaneous barrier function in vivo and epidermal thickening. Mice that express a constitutively active Signal Transducer and Activator of Transcription 6 (STAT6VT) have increased Th2 cells and a predisposition to allergic inflammation were used in these studies, they demonstrate that topical treatment with the irritant sodium lauryl sulfate (SLS) caused increased transepidermal water loss and epidermal thickening in STAT6VT mice over similarly treated wild-type mice. The proliferation marker Ki-67 was increased in the epidermis of STAT6VT compared to the wild-type mice. However, these differences do not appear to be linked to the addition of an irritant as control-treated STAT6VT skin also exhibited elevated Ki-67 levels, suggesting that the increased epidermal thickness in SLS-treated STAT6VT mice is primarily driven by epidermal cell hypertrophy rather than an increase in cellular proliferation. Our results suggest that an environment with increased Th2 cytokines results in abnormal responses to topical irritants.

Original languageEnglish
Pages (from-to)65-71
Number of pages7
JournalArchives of Dermatological Research
Volume304
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Sodium Dodecyl Sulfate
Irritants
T-Lymphocytes
Skin
Atopic Dermatitis
STAT6 Transcription Factor
Cytokines
Th2 Cells
Skin Diseases
Epidermis
Interleukin-4
Causality
Hypertrophy
Cell Proliferation
Inflammation
Water
Therapeutics

Keywords

  • Atopic dermatitis
  • Interleukin-4
  • STAT6 V547A/T548A mutation
  • T-helper type 2 cells
  • Transepidermal water loss

ASJC Scopus subject areas

  • Dermatology

Cite this

@article{b82775a2c3fc4e858ff1d65502459a2b,
title = "Increased skin barrier disruption by sodium lauryl sulfate in mice expressing a constitutively active STAT6 in T cells",
abstract = "Atopic dermatitis (AD) is a pruritic, chronic inflammatory skin disease that affects 10-20{\%} of children and 1-3{\%} of adults worldwide. Recent studies have indicated that the ability of Th2 cytokines, such as interleukin-4 (IL-4) to regulate skin barrier function may be a predisposing factor for AD development. The present studies examined the ability of increased Th2 activity to affect cutaneous barrier function in vivo and epidermal thickening. Mice that express a constitutively active Signal Transducer and Activator of Transcription 6 (STAT6VT) have increased Th2 cells and a predisposition to allergic inflammation were used in these studies, they demonstrate that topical treatment with the irritant sodium lauryl sulfate (SLS) caused increased transepidermal water loss and epidermal thickening in STAT6VT mice over similarly treated wild-type mice. The proliferation marker Ki-67 was increased in the epidermis of STAT6VT compared to the wild-type mice. However, these differences do not appear to be linked to the addition of an irritant as control-treated STAT6VT skin also exhibited elevated Ki-67 levels, suggesting that the increased epidermal thickness in SLS-treated STAT6VT mice is primarily driven by epidermal cell hypertrophy rather than an increase in cellular proliferation. Our results suggest that an environment with increased Th2 cytokines results in abnormal responses to topical irritants.",
keywords = "Atopic dermatitis, Interleukin-4, STAT6 V547A/T548A mutation, T-helper type 2 cells, Transepidermal water loss",
author = "Dasilva, {Sonia C.} and Sahu, {Ravi P.} and Raymond Konger and Susan Perkins and Mark Kaplan and Jeffrey Travers",
year = "2012",
month = "1",
doi = "10.1007/s00403-011-1168-2",
language = "English",
volume = "304",
pages = "65--71",
journal = "Archives of Dermatological Research",
issn = "0340-3696",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Increased skin barrier disruption by sodium lauryl sulfate in mice expressing a constitutively active STAT6 in T cells

AU - Dasilva, Sonia C.

AU - Sahu, Ravi P.

AU - Konger, Raymond

AU - Perkins, Susan

AU - Kaplan, Mark

AU - Travers, Jeffrey

PY - 2012/1

Y1 - 2012/1

N2 - Atopic dermatitis (AD) is a pruritic, chronic inflammatory skin disease that affects 10-20% of children and 1-3% of adults worldwide. Recent studies have indicated that the ability of Th2 cytokines, such as interleukin-4 (IL-4) to regulate skin barrier function may be a predisposing factor for AD development. The present studies examined the ability of increased Th2 activity to affect cutaneous barrier function in vivo and epidermal thickening. Mice that express a constitutively active Signal Transducer and Activator of Transcription 6 (STAT6VT) have increased Th2 cells and a predisposition to allergic inflammation were used in these studies, they demonstrate that topical treatment with the irritant sodium lauryl sulfate (SLS) caused increased transepidermal water loss and epidermal thickening in STAT6VT mice over similarly treated wild-type mice. The proliferation marker Ki-67 was increased in the epidermis of STAT6VT compared to the wild-type mice. However, these differences do not appear to be linked to the addition of an irritant as control-treated STAT6VT skin also exhibited elevated Ki-67 levels, suggesting that the increased epidermal thickness in SLS-treated STAT6VT mice is primarily driven by epidermal cell hypertrophy rather than an increase in cellular proliferation. Our results suggest that an environment with increased Th2 cytokines results in abnormal responses to topical irritants.

AB - Atopic dermatitis (AD) is a pruritic, chronic inflammatory skin disease that affects 10-20% of children and 1-3% of adults worldwide. Recent studies have indicated that the ability of Th2 cytokines, such as interleukin-4 (IL-4) to regulate skin barrier function may be a predisposing factor for AD development. The present studies examined the ability of increased Th2 activity to affect cutaneous barrier function in vivo and epidermal thickening. Mice that express a constitutively active Signal Transducer and Activator of Transcription 6 (STAT6VT) have increased Th2 cells and a predisposition to allergic inflammation were used in these studies, they demonstrate that topical treatment with the irritant sodium lauryl sulfate (SLS) caused increased transepidermal water loss and epidermal thickening in STAT6VT mice over similarly treated wild-type mice. The proliferation marker Ki-67 was increased in the epidermis of STAT6VT compared to the wild-type mice. However, these differences do not appear to be linked to the addition of an irritant as control-treated STAT6VT skin also exhibited elevated Ki-67 levels, suggesting that the increased epidermal thickness in SLS-treated STAT6VT mice is primarily driven by epidermal cell hypertrophy rather than an increase in cellular proliferation. Our results suggest that an environment with increased Th2 cytokines results in abnormal responses to topical irritants.

KW - Atopic dermatitis

KW - Interleukin-4

KW - STAT6 V547A/T548A mutation

KW - T-helper type 2 cells

KW - Transepidermal water loss

UR - http://www.scopus.com/inward/record.url?scp=84857058977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857058977&partnerID=8YFLogxK

U2 - 10.1007/s00403-011-1168-2

DO - 10.1007/s00403-011-1168-2

M3 - Article

VL - 304

SP - 65

EP - 71

JO - Archives of Dermatological Research

JF - Archives of Dermatological Research

SN - 0340-3696

IS - 1

ER -